1. Home
  2. CKPT vs VSTM Comparison

CKPT vs VSTM Comparison

Compare CKPT & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CKPT
  • VSTM
  • Stock Information
  • Founded
  • CKPT 2014
  • VSTM 2010
  • Country
  • CKPT United States
  • VSTM United States
  • Employees
  • CKPT N/A
  • VSTM N/A
  • Industry
  • CKPT Biotechnology: Pharmaceutical Preparations
  • VSTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • CKPT Health Care
  • VSTM Health Care
  • Exchange
  • CKPT Nasdaq
  • VSTM Nasdaq
  • Market Cap
  • CKPT N/A
  • VSTM 132.0M
  • IPO Year
  • CKPT 2017
  • VSTM 2012
  • Fundamental
  • Price
  • CKPT $3.77
  • VSTM $3.88
  • Analyst Decision
  • CKPT Strong Buy
  • VSTM Strong Buy
  • Analyst Count
  • CKPT 2
  • VSTM 8
  • Target Price
  • CKPT $12.00
  • VSTM $14.57
  • AVG Volume (30 Days)
  • CKPT 946.5K
  • VSTM 1.1M
  • Earning Date
  • CKPT 11-11-2024
  • VSTM 11-06-2024
  • Dividend Yield
  • CKPT N/A
  • VSTM N/A
  • EPS Growth
  • CKPT N/A
  • VSTM N/A
  • EPS
  • CKPT N/A
  • VSTM N/A
  • Revenue
  • CKPT $78,000.00
  • VSTM $10,000,000.00
  • Revenue This Year
  • CKPT N/A
  • VSTM N/A
  • Revenue Next Year
  • CKPT $151,162.55
  • VSTM $125.69
  • P/E Ratio
  • CKPT N/A
  • VSTM N/A
  • Revenue Growth
  • CKPT N/A
  • VSTM N/A
  • 52 Week Low
  • CKPT $1.36
  • VSTM $2.10
  • 52 Week High
  • CKPT $3.95
  • VSTM $14.22
  • Technical
  • Relative Strength Index (RSI)
  • CKPT 84.67
  • VSTM 63.77
  • Support Level
  • CKPT $2.37
  • VSTM $3.11
  • Resistance Level
  • CKPT $2.54
  • VSTM $3.76
  • Average True Range (ATR)
  • CKPT 0.27
  • VSTM 0.33
  • MACD
  • CKPT 0.10
  • VSTM 0.04
  • Stochastic Oscillator
  • CKPT 88.60
  • VSTM 94.26

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks: